Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors.

Fletcher KA, Goodman RS, Lawless A, Woodford R, Fa’ak F, Tipirneni A, Patrinely JR, Yeoh HL, Rapisuwon S, Haydon A, Osman I, Mehnert JM, Long GV, Sullivan RJ, Carlino MS, Menzies AM, Dewan AK, Johnson DB. JAMA Dermatol, (Mar 12 2025), doi:10.1001/jamadermatol.2025.0025. ^{TOP 10%}